Authors:
Girard, PM
Schneider, V
Dehee, A
Mariot, P
Jacomet, C
Delphin, N
Damond, F
Carcelain, G
Autran, B
Saimot, AG
Nicolas, JC
Rozenbaum, W
Citation: Pm. Girard et al., Treatment interruption after one year of triple nucleoside analogue therapy for primary HIV infection, AIDS, 15(2), 2001, pp. 275-277
Authors:
Serfaty, L
Costagliola, D
Wendum, D
Picard, O
Meyohas, MC
Girard, PM
Lebas, J
Delamare, C
Poupon, R
Housset, C
Citation: L. Serfaty et al., Impact of early-untreated HIV infection on chronic hepatitis C in intravenous drug users: a case-control study, AIDS, 15(15), 2001, pp. 2011-2016
Authors:
Desire, N
Dehee, A
Schneider, V
Jacomet, C
Goujon, C
Girard, PM
Rozenbaum, W
Nicolas, JC
Citation: N. Desire et al., Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay, J CLIN MICR, 39(4), 2001, pp. 1303-1310
Authors:
Girard, PM
Pegram, PS
Diquet, B
Anderson, R
Raffi, F
Tubiana, R
Sereni, D
Boerner, D
Citation: Pm. Girard et al., Phase II placebo-controlled trial of fozivudine tidoxil for HIV infection:Pharmacokinetics, tolerability, and efficacy, J ACQ IMM D, 23(3), 2000, pp. 227-235
Authors:
Girard, PM
Guiguet, M
Bollens, D
Goderel, I
Meyohas, MC
Lecomte, I
Raguin, G
Frottier, J
Rozenbaum, W
Jaillon, P
Citation: Pm. Girard et al., Long-term outcome and treatment modifications in a prospective cohort of human immunodeficiency virus type 1-infected patients on triple-drug antiretroviral regimens, CLIN INF D, 31(4), 2000, pp. 987-994
Authors:
Gozalbes, R
Brun-Pascaud, M
Garcia-Domenech, R
Galvez, J
Girard, PM
Doucet, JP
Derouin, F
Citation: R. Gozalbes et al., Prediction of quinolone activity against Mycobacterium avium by molecular topology and virtual computational screening, ANTIM AG CH, 44(10), 2000, pp. 2764-2770
Authors:
Gozalbes, R
Brun-Pascaud, M
Garcia-Domenech, R
Galvez, J
Girard, PM
Doucet, JP
Derouin, F
Citation: R. Gozalbes et al., Anti-Toxoplasma activities of 24 quinolones and fluoroquinolones in vitro:Prediction of activity by molecular topology and virtual computational techniques, ANTIM AG CH, 44(10), 2000, pp. 2771-2776
Authors:
Girard, PM
Foray, N
Stumm, M
Waugh, A
Riballo, E
Maser, RS
Phillips, WP
Petrini, J
Arlett, CF
Jeggo, PA
Citation: Pm. Girard et al., Radiosensitivity in Nijmegen Breakage syndrome cells is attributable to a repair defect and not cell cycle checkpoint defects, CANCER RES, 60(17), 2000, pp. 4881-4888
Authors:
Bouscarat, F
Levacher, M
Dazza, MC
Chau, F
Desforges, B
Muffat-Joly, M
Matheron, S
Girard, PM
Sinet, M
Citation: F. Bouscarat et al., Prospective study of CD8(+) lymphocyte activation in relation to viral load in HIV-infected patients with >= 400 CD4(+) lymphocytes per microliter, AIDS RES H, 15(16), 1999, pp. 1419-1425
Authors:
Pillet, S
Prevost, MH
Preira, A
Girard, PM
Rogine, N
Hakim, J
Gougerot-Pocidalo, MA
Elbim, C
Citation: S. Pillet et al., Monocyte expression of adhesion molecules in HIV-infected patients: Variations according to disease stage and possible pathogenic role, LAB INV, 79(7), 1999, pp. 815-822
Authors:
Elbim, C
Pillet, S
Prevost, MH
Preira, A
Girard, PM
Rogine, N
Matusani, H
Hakim, J
Israel, N
Gougerot-Pocidalo, MA
Citation: C. Elbim et al., Redox and activation status of monocytes from human immunodeficiency virus-infected patients: Relationship with viral load, J VIROLOGY, 73(6), 1999, pp. 4561-4566
Authors:
Weiss, L
Ancuta, P
Girard, PM
Bouhlal, H
Roux, A
Cavaillon, NH
Kazatchkine, MD
Citation: L. Weiss et al., Restoration of normal interleukin-2 production by CD4(+) T cells of human immunodeficiency virus-infected patients after 9 months of highly active antiretroviral therapy, J INFEC DIS, 180(4), 1999, pp. 1057-1063